{"id":19092,"date":"2026-06-10T20:38:00","date_gmt":"2026-06-10T18:38:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=4b4497b303e6489037e9156b48995d0b"},"modified":"2026-06-10T20:38:00","modified_gmt":"2026-06-10T18:38:00","slug":"tanner-health-and-healthliant-ventures-partner-with-optellum-to-bring-ai-for-lung-health-to-the-region","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=19092","title":{"rendered":"Tanner Health and Healthliant Ventures Partner With Optellum to Bring AI for Lung Health to the Region"},"content":{"rendered":"

CARROLLTON, Ga.--(BUSINESS WIRE)--Tanner Health and Healthliant Ventures announce the launch of Optellum\u2019s Virtual Nodule Clinic\u00ae (VNC), an artificial intelligence (AI) platform designed to assist care teams in identifying, risk assessing and managing patients with potentially cancerous lung nodules.<\/p><\/a><\/a>

\nLung cancer remains the leading cause of cancer deaths worldwide, in large part due to late diagnosis. Optellum\u2019s lung cancer prediction (LCP) AI solution addresses this challenge by using advanced imaging analytics and machine learning to assess the risk that a lung nodule detected on a CT scan is malignant. This allows clinicians to identify high-risk patients earlier and avoid unnecessary procedures for those at minimal risk.<\/p>

\nThe partnership marks another milestone in the health system\u2019s commitment to bringing world-class innovation to the communities it serves.<\/p>

\nThis collaboration enables Tanner\u2019s team to use Optellum\u2019s AI to support earlier, more accurate identification of patients at risk of lung cancer. The aim is to improve lung cancer outcomes for patients across west Georgia and east Alabama.<\/p>

\n\u201cFor a regional health system like ours, innovation isn\u2019t about size \u2014 it\u2019s about intent,\u201d said Ben Camp, MD, chief medical officer of Tanner Health. \u201cWe\u2019re proud to bring the kind of technology that you\u2019d expect to see in major academic centers right here to our corner of the world. It\u2019s another example of how we\u2019re investing in the tools and partnerships that help our clinicians provide the best care for our patients.\u201d<\/p>

\nOptellum\u2019s Virtual Nodule Clinic uses advanced imaging AI and clinical data to help physicians assess lung nodules and determine which patients may need further diagnostic workup. By improving risk stratification, the technology supports earlier detection of lung cancer while reducing unnecessary invasive procedures.<\/p>

\n\u201cEarly detection is key to saving lives, and AI can help us identify lung cancer before symptoms appear,\u201d said Anil Dhople, MD, a board-certified radiation oncologist and medical director and quality advisor at the Roy Richards, Sr. Cancer Center. \u201cThrough our partnership with Optellum, we\u2019re introducing proven, FDA-cleared technology that enhances how clinicians evaluate lung nodules, helping us make faster, more informed decisions and deliver the best possible outcomes for our patients. This technology is especially valuable in rural communities, where longer travel distances, limited access to specialists and delays in treatment can negatively affect outcomes. By improving risk assessment and supporting earlier intervention, we can help ensure patients receive the timely care they need.\u201d<\/p>

\nThe collaboration is the latest initiative through Healthliant Ventures, which was established to connect Tanner with emerging healthcare technologies that can transform care delivery and outcomes.<\/p>

\n\u201cOptellum\u2019s AI solution aligns perfectly with our mission to provide quality healthcare services and serve as a leader to provide health education, support services and care across our community,\u201d said Loy Howard, president and CEO of Tanner Health. \u201cIt empowers our clinicians with actionable insights and helps ensure patients receive the right care at the right time.\u201d<\/p>

\nOptellum\u2019s platform is already in use across leading academic and community hospitals worldwide and has demonstrated measurable improvements in diagnostic accuracy and workflow efficiency.<\/p>

\n\u201cThis partnership with Tanner demonstrates how a regional system can lead the way by embracing innovative, clinically validated solutions in a way that benefits both patients and the broader healthcare ecosystem,\u201d said Johnathan Watkins, CEO of Optellum.<\/p>

\nThe deployment of Optellum at Tanner marks one of the first regional health systems in Georgia to implement the technology system-wide.<\/p>

\nAbout Optellum<\/b><\/p>

\nOptellum is a commercial-stage AI healthcare company dedicated to revolutionizing early diagnosis and treatment of lung disease, starting with one of the deadliest, lung cancer.<\/p>

\nOptellum is building LungOS\u00ae<\/sup>, the<\/i> end-to-end AI-powered platform for thoracic care. Its flagship product, Virtual Nodule Clinic (VNC) with Lung Cancer Prediction AI (LCP), is the world\u2019s first FDA-cleared and reimbursed software-as-a-medical-device (SaMD) solution for AI-powered lung cancer prioritization and diagnostic support. Clinicians trust the Optellum solution to aid them in making the most appropriate life-saving treatment decisions for their patients. Backed by real-world clinical evidence, Optellum\u2019s solution accelerates the diagnostic care pathway by enabling early patient identification, enhancing prioritization, and improving clinicians\u2019 efficiency, reducing time to guideline-recommended treatment. Optellum VNC is FDA cleared, CE-MDR marked, UKCA marked, and TGA-approved.<\/p>

\nOptellum is headquartered in Oxford, UK, and has an office in Houston, Texas, US.<\/p>

\nAbout Tanner Health<\/b><\/p>

\nTanner Health is a five-hospital non-profit health system providing convenient, personalized health care to communities across west Georgia and east Alabama. Tanner Health physicians and staff provide the latest technology and treatment options to advance the health of our patients. In addition to its regional hospitals and care centers, Tanner operates Tanner Medical Group, one of metro Atlanta\u2019s largest multi-specialty physician groups. Learn more at tanner.org<\/a>.<\/p>

\nAbout Healthliant Ventures<\/b><\/p>

\nHealthliant Ventures is Tanner Health\u2019s innovation arm, partnering with healthcare startups to validate and co-develop transformative solutions that enhance patient care and improve outcomes. Dedicated to driving innovation across the healthcare landscape, Healthliant Ventures focuses on technologies that deliver measurable clinical, operational and fiscal impact. Learn more at healthliant.com<\/a>.<\/p> Contacts<\/b>

\nJessica Swafford\nPhone: 770-235-2135\njessica.swafford@tanner.org<\/a><\/p>","protected":false},"excerpt":{"rendered":"

CARROLLTON, Ga.–(BUSINESS WIRE)–Tanner Health and Healthliant Ventures announce the launch of Optellum\u2019s Virtual Nodule Clinic\u00ae (VNC), an artificial intelligence (AI) platform designed to assist care teams in identifying, risk assessing and managing …<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-19092","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/19092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19092"}],"version-history":[{"count":2,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/19092\/revisions"}],"predecessor-version":[{"id":19094,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/19092\/revisions\/19094"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19092"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19092"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}